PubMed

BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.

Temple R, Stockbridge NL.

Ann Intern Med. 2007 Jan 2;146(1):57-62.PMID: 17200223 [PubMed - indexed for MEDLINE]Related articlesFree article

BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.

Bibbins-Domingo K, Fernandez A.

Ann Intern Med. 2007 Jan 2;146(1):52-6. Erratum in: Ann Intern Med. 2007 Apr 17;146(8):616. PMID: 17200222 [PubMed - indexed for MEDLINE]Related articlesFree article

Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.

Ellison GT, Kaufman JS, Head RF, Martin PA, Kahn JD.

J Law Med Ethics. 2008 Fall;36(3):449-57.PMID: 18840235 [PubMed - indexed for MEDLINE]Related articlesFree article

BiDil for heart failure in black patients.

Kahn JD.

Ann Intern Med. 2007 Aug 7;147(3):215; author reply 215-6. No abstract available. PMID: 17679713 [PubMed - indexed for MEDLINE]Related articlesFree article

BiDil for heart failure in black patients.

Bibbins-Domingo K, Fernandez A.

Ann Intern Med. 2007 Aug 7;147(3):214-5; author reply 215-6. No abstract available. PMID: 17679712 [PubMed - indexed for MEDLINE]Related articlesFree article

BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.

Carmody MS, Anderson JR.

Cardiol Rev. 2007 Jan-Feb;15(1):46-53. Review.PMID: 17172884 [PubMed - indexed for MEDLINE]Related articles

Prescribing BiDil: is it black and white?

Haga SB, Ginsburg GS.

J Am Coll Cardiol. 2006 Jul 4;48(1):12-4. Epub 2006 Jun 9.PMID: 16814642 [PubMed - indexed for MEDLINE]Related articles

U.S. to review drug intended for one race.

Saul S.

NY Times (Print). 2005 Jun 13:A1, A15. No abstract available. PMID: 15966118 [PubMed - indexed for MEDLINE]Related articles

A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.

Cheng JW.

Clin Ther. 2006 May;28(5):666-78. Review.PMID: 16861089 [PubMed - indexed for MEDLINE]Related articles

FDA approves heart drug for black patients.

Meadows M.

FDA Consum. 2005 Sep-Oct;39(5):8-9.PMID: 16419285 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.

Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.

Clin Ther. 2009 Mar;31(3):632-43.PMID: 19393854 [PubMed - indexed for MEDLINE]Related articles

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

N Engl J Med. 2004 Nov 11;351(20):2049-57. Epub 2004 Nov 8. Erratum in: N Engl J Med. 2005 Mar 24;352(12):1276. PMID: 15533851 [PubMed - indexed for MEDLINE]Related articlesFree article

Bidil: recontextualizing the race debate.

Séguin B, Hardy B, Singer PA, Daar AS.

Pharmacogenomics J. 2008 Jun;8(3):169-73. Epub 2008 Jan 15. No abstract available. PMID: 18195727 [PubMed - indexed for MEDLINE]Related articles

Misreading race and genomics after BiDil.

Kahn J.

Nat Genet. 2005 Jul;37(7):655-6. No abstract available. PMID: 15990879 [PubMed - indexed for MEDLINE]Related articles

Race-based therapeutics.

Bloche MG.

N Engl J Med. 2004 Nov 11;351(20):2035-7. Epub 2004 Nov 8. No abstract available. PMID: 15533852 [PubMed - indexed for MEDLINE]Related articles

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

Carson P, Ziesche S, Johnson G, Cohn JN.

J Card Fail. 1999 Sep;5(3):178-87.PMID: 10496190 [PubMed - indexed for MEDLINE]Related articles

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al.

N Engl J Med. 1991 Aug 1;325(5):303-10.PMID: 2057035 [PubMed - indexed for MEDLINE]Related articles

Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.

Thadani U, Jacob RG.

Drugs Today (Barc). 2008 Dec;44(12):925-37.PMID: 19198701 [PubMed - indexed for MEDLINE]Related articles

The paradox of race in the Bidil debate.

Crawley L.

J Natl Med Assoc. 2007 Jul;99(7):821-2. No abstract available. PMID: 17668653 [PubMed - indexed for MEDLINE]Related articlesFree article

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.

Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

Circulation. 2007 Apr 3;115(13):1747-53. Epub 2007 Mar 19.PMID: 17372175 [PubMed - indexed for MEDLINE]Related articlesFree article